WuXi Biologics (Cayman) Inc. WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.

2269

Kedudukan dalam Saham #991
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Harga Saham
$5.73
Modal Pasaran
$23.57B
Perubahan (1 hari)
-9.03%
Perubahan (1 tahun)
24.25%
Negara
CN
Perdagangan WuXi Biologics (Cayman) Inc. (2269)

Kategori

Healthcare
Sejarah pecahan saham untuk WuXi Biologics (Cayman) Inc. (2269)
Saham WuXi Biologics (Cayman) Inc. (simbol: 2269) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 22, 2026.
Satu saham 2269 yang dibeli sebelum Oct 22, 2026 kini bersamaan dengan 0 saham 2269.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
US
1 x3
AU
0 -
NL
0 -
CH